Bad Soden, Germany,
14
November
2023
|
14:45
Europe/Amsterdam

Industrial gases specialist Messer completes acquisition of joint venture Messer Industries - GIC is new strategic partner

  • Messer completes acquisition of all shares in Messer Industries from minority owner CVC Capital Partners Fund VII
  • GIC becomes Messer’s new strategic partner
  • All regions will be represented on the Management Board of Messer SE & Co. KGaA
  • CEO Bernd Eulitz: "As a successful gases group in Asia, Europe and the Americas, we will be even stronger and drive forward our ambitious growth plans together with GIC as our new partner."

Messer, the world's leading privately owned specialist for industrial, medical and specialty gases, has completed the acquisition of the joint venture Messer Industries, following receipt of various regulatory approvals. With sole ownership of Messer Industries, Messer can now grow as one globally positioned gases group.

In addition GIC, a global institutional investor, will now become a long-term minority shareholder in Messer. GIC has a track record of partnering with family businesses around the world and supports Messer's strategy for sustainable, profitable growth.

Bernd Eulitz, CEO of Messer, said: "With the now approved partnership with GIC and the full acquisition of Messer Industries, Messer is opening a new chapter in its 125-year corporate history. As a gases group successful in Asia, Europe and the Americas, we will be even stronger and drive forward our ambitious plans with GIC as our new partner. Messer has enormous potential with its 11,000 employees worldwide. We want to move closer to the big players in the industry as the number one challenger."

The acquisition of Messer Industries marks the end of the successful collaboration between Messer and CVC Capital Partners on the previous joint venture, which comprised Messer's companies in North and South America as well as Western Europe.

Messer sees major opportunities in all its business areas worldwide. The company is aiming for greater diversification of its offering with a focus on particularly promising sectors or through partnerships in the wake of the green energy transition. Messer expects significant increases in sales and earnings and has the potential to roughly double its business volume by the end of the decade.

About GIC

GIC is a leading global investment firm established in 1981 to secure Singapore’s financial future. As the manager of Singapore’s foreign reserves, GIC takes a long-term, disciplined approach to investing and is uniquely positioned across a wide range of asset classes and active strategies globally. These include equities, fixed income, real estate, private equity, venture capital and infrastructure. Its long-term approach, multi-asset capabilities and global connectivity enable it to be an investor of choice. GIC seeks to add meaningful value to its investments. Headquartered in Singapore, GIC has a global talent force of over 2,100 people in 11 key financial cities and has investments in over 40 countries.

For more information, please visit www.gic.com.sg or follow on LinkedIn.

Media contact

Samantha Chiene
Vice President, Corporate Communicatons (London)
samanthachiene@gic.com.sg

About Messer

Messer is the world's largest privately held specialist for industrial, medical and specialty gases. Messer's Gases for Life are used in industry, environmental protection, medicine, the food industry, welding and cutting technology, 3D printing, construction, research and science. As a global player, Messer offers its sustainable products and services in Asia, Europe and the Americas. More than 11,000 employees work together successfully with a focus on diversity and mutual respect.

In most industrial processes, gases are just as important as water and electricity and play a major role in their decarbonization – through the use of green hydrogen, for example. Messer offers one of the largest product portfolios in the market and develops and optimizes application technologies for gases in state-of-the-art competence centers.

As a pharmaceutical company, Messer supplies medical and pharmaceutical gases and turnkey solutions and has a proven track record as a reliable provider of vital products – in pandemic situations, for example.

Founded in 1898, the company’s headquarters are located in Bad Soden, near Frankfurt, Germany.

In 2022, Messer generated an expected consolidated sales of 4.164 billion* euros.

* Sum of Messer Group and Messer Industries, which includes 100 percent of the at-equity holding Messer Industries.

http://www.messergroup.com

https://applications.messergroup.com

http://www.gasesforlife.de